Q2 results destroyed Cadila ont he exchanges with virtually no growth in domestic sales coming thru despite it being 38% of the business for Cadilla
Earlier Rakesh Juhnjhunwala completed his exit from Lupin for a 50% portion of his and his family’s holdings.. Sun Pharma has been unable to capitalise on its increasing returns asmarket waits and watches it in tandem with the Sensex P/e and /or questions its diversifications while Dr Reddy is still recovering from operational fall throughs and DEPB wischeme withdrawals as merkets teeter on the 5600 mark itself for the sixth or seventh time since new muhurat trading
Wipro in the mean time played true to form destroying profits ( down 3%) and losing steam with a $2.15 bln topline ruling out too quick a recovery under new management and likely to drop out of Top 5 indian It positions sooner than later
The India Investment Post (earlier india.advantages.us) 